Addicted, Alone, Forgotten, and Ashamed

Similar documents
Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Understanding and Combating the Heroin Epidemic

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

Medication Treatment and Opioid Use Disorder

ROSC & MAT II: Opioid Treatment Services

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

The Importance of Psychological Treatment and Behavioral Support

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Treatment Issues: The Opiate Crisis Among Us

Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

Opiate Use Disorder and Opiate Overdose

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut

Opioid Use Disorder Treatment Initiation in Diverse Settings

The Chronic Disease of Addiction Evidence and Lessons from Practice

Opioid use disorder: Supporting recovery with a medication-assisted treatment approach

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

Medications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC

Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story

9/17/2018 MISSION IMPOSSIBLE: IF YOU CHOOSE TO ACCEPT MISSION JOIN JUSTICE LEAGUE I M POSSIBLE HEPBURN

Coalition Strategies Across The Continuum of Care

Medication Assisted Treatment

EFFECTIVE AND RESPONSIBLE MEDICATION ASSISTED TREATMENT

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

Mark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC

Opioids Research to Practice

HOPE Agenda. Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN ASSEMBLY DISTRICT 89

Opioid Use Disorders as a Brain Disease Why MAT is so important. Ron Jackson, M.S.W., L.I.C.S.W.

Opioids Research to Practice

Addiction Overview. Diane A. Rothon MD. Causes Consequences Treatments. Methadone/Buprenorphine 101 April 1, 2017

MAT in the Corrections Setting

Resist the Opioid Pendulum: Understanding Opioids and Pain, and how they relate to Addiction

7/7/2016 Journal of the American Medical Association,

Treatment Approaches for Drug Addiction

Building capacity for a CHC response to Ontario's Opioid Crisis

POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE

Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity

OPIOIDS IN AMERICA. A complex crisis. A comprehensive response.

Substance Abuse Suboxone Treatment

Beyond Birth: A Comprehensive Recovery Center serving parenting women

Attitudes Toward Medication-Assisted Treatment Within a Drug Court Program. Caroline Allison. Dr. Kathleen Moore, Ph.D.

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Methadone and buprenorphine for the management of opioid dependence

5/30/ New England Summer School Lindy S. Keller, M.S., MLADC - NH Bureau of Drug & Alcohol Services. Objectives

Drug Addiction Is a Disease So What Do We Do about It?

Management of Opioid Use Disorder in Primary Care

MGH Substance Use Disorder Initiative. Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP MGH ED Christopher Shaw, RN, ANP, PMHNP-BC, CARN-AP MGH ACT

Opioids and Chronic Pain

The science of the mind: investigating mental health Treating addiction

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

The Opioid Crisis in the U.S.

Opioids and Opioid Addiction: Practical Management Approaches

Strategies to Manage The Opioid Crisis

OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL

Open Recovery Ending the Stigma Fueling Addiction

How serious is the opiate problem in Fairfield County?

2/24/2017. Pregnant Women Who Use Drugs: Stigma, Science and Society

WELCOME AND INTRODUCTIONS

HARM REDUCTION & TREATMENT. Devin Reaves MSW

Data Driven Strategies

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

2/21/2018. What are Opioids?

Serious Mental Illness and Opioid Use Disorder

KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH

Discrimination & the Opioid Crisis

the facts about BUPRENORPHINE for Treatment of Opioid Addiction

Recovery U: Medication Assisted Treatment (MAT)

ADAPTING YOUR COURT STRUCTURE

Welcome to the Opioid Overdose Prevention Project

Treating Opioid Addiction

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

Advancing Addiction Science to Address the Opioid Crisis

Substance Use Disorders in Primary Care

Building Community Coalitions to Address the Opioid Crisis

Restoration of Parenting Ability Through Treatment for Substance Use Disorders

Opioid Treatment in North Carolina SEPTEMBER 13, 2016

Prescription Drug Impact in the Workplace

Drug demand reduction and harm reduction: complementary approaches. Gilberto Gerra Chief Global Challenges Section Division for Operations

Noel Schenk MD. Davis Behavioral Health

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.

Buprenorphine as a Treatment Option for Opioid Use Disorder

Methadone and Naltrexone ER

Substance Use Disorder Part One: The Basics of Recovery

Opioids Research to Practice

Opioid Dependence and Buprenorphine Management

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer

Medication Assisted Treatment of Substance Use Disorders

BENZODIAZEPINES: WHAT YOU DON T KNOW CAN HURT YOU

Screening, Identification, Counseling, and Treatment of Opioid Use Disorder

Treatment Team Approaches in Substance Abuse Treatment

Insight Addictionary

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS

Disclosures. Objectives 2/5/2018. Women and opioid use disorder: Optimizing care during pregnancy and beyond

Chronic Pain in Women and its Relationship to Opioid Addiction

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Mass General s Substance Use Disorder Initiative

Transcription:

Addicted, Alone, Forgotten, and Ashamed Colleen T. LaBelle, MSN, RN-BC, CARN Nurse Manager, Office-Based Addiction Treatment Director, STATE OBAT, Mass Department Public Health

Overdose Deaths per 100,000 1999 Centers for Disease Control and Prevention and the National Center for Health Statistics

Centers for Disease Control and Prevention and the National Center for Health Statistics Overdose Deaths per 100,000 2014

Worrisome Trends and Associations OPR=Opioid Pain Relievers OPR Sales kg/10,000 OPR Overdose Deaths/100,000 OPR Treatment Admissions/10,000 x NAS NICU Admissions/1,000 x x x x x x 1999 2001 2003 2005 2007 2009 2011 201 2013 2 MMWR Nov 4, 2011 Volkow ND et al. N Engl J Med. 2014 Tolia VN et al. N Engl J Med. 2015

How We Got Here. Created by Lauren Melby, MPP student at Brandeis University, 2015 7

Poor access to effective medication Clamp down on prescription opioids since 2009 Jail, prison, detox and drug-free treatment à loss of tolerance Recurrent disease Cheap, street heroin, pills of high & varied potency Overdose

The Addiction Crisis

The Addiction Crisis

>129 People Die From Drug Overdoses Each Day in The United States: One Person Every 11 Seconds.

Prescription Opioid Path to Heroin 00240592 Unknown 80% of individuals who reported that they began using heroin in the past year had previous prescription opioid misuse Kuehn BM. JAMA 2013; 310:1433-1434

Opioid Misuse Risk Known Risk Factors Good Predictors for Prescription Opioid Misuse Young age (less than 45 years) Personal history of substance use disorder Illicit, prescription, alcohol, nicotine Family history of substance use disorder Legal history DUI, incarceration Mental health problems History of sexual abuse Akbik H, et al. J Pain Symptom Manage. 2006 Ives J, et al. BMC Health Serv Res. 2006 Liebschutz JM, et al. J Pain. 2010 Michna E, et al. J Pain Symptom Manage. 2004 Reid MC, et al. J Gen Intern Med. 2002

Opioids in Perspective The efficacy and safety of chronic opioid therapy for chronic pain has been inadequately studied * Opioid prescribing needs to be more selective and conservative Opioids for chronic pain help some patients harm some patients are only one tool for managing severe chronic pain are indicated only when alternative safer treatment options are inadequate Chou R et al. Ann Intern Med 2015 Dowell D et al. JAMA 2016 Manchikanti L et al. Pain Physician 2011 Reuben DB et al. Ann Intern Med 2015 Volkow ND, McLellan T. N Engl J Med 2016

Addiction Involves Multiple Factors

Neurotoxicity AIDS, Cancer Mental illness Homelessness Crime Violence Health care Productivity Accidents

State without Stigma.

End The Stigma Research tells us that addiction is a Disease like any other, that its roots are Genetic, Biological, and Environmental. But rather than treating it like the disease that it is, society treats addiction like a moral failure or even a crime. Stigma: Self: Shame, devalued, flawed Social: blame, moral failing Structural: Institutional rules, polices, practices Denied evidence based treatment, treatment bias NIDA

Addiction: Is A Disease.

Addiction: the Disease 1956: American Medical Association The illness can be described The course of the illness is predictable and progressive The disease is primary that is, it is not just a symptom of some other underlying disorder It is permanent It is terminal: If left untreated, can lead to morbidity and mortality Solutions Outpatient Services; Texas Department of State Health Services

Your Brain on Drugs in the 1980 s

www.drugabuse.gov

Acute to chronic opioid use Withdrawal Normal Euphoria Acute use Tolerance and Physical Dependence Chronic use

Treatment Non Compliance Rates Are Similar for Drug Dependence and Other Chronic Illnesses Percent of Patience Who Relapse 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 40% to 60% 30% to 50% 50% to 70% 50% to 70% Drug Dependence Type I Diabetes Hypertension Asthma Source: McLellan, A.T. et al., JAMA, Vol 284(13), October4, 2000.

Cost of Addiction to Workforce: 2009 67% Current Substance Users are Employed 48% Employed Fulltime 19% Employed Part time 13% Unemployed Turnover/absenteeism Current substance users twice as likely: 2 or more jobs/year : 12.3 vs. 5.1% National Drug Intelligence Center. National Threat Assessment: the Economic Impact of Illicit Drug Use on American Society. May 2011. Department of Justice, Washington, DC. 2 Substance Abuse and Mental Health Services Administration [SAMHSA]. 2009 National Survey on Drug Use and Health [NSDUH] (September 2010).

What do We Believe?? Myths & Facts

Common Beliefs about Medication Assisted Treatment: Patients are still addicted FACT: Addiction is pathologic use of a substance and may or may not include physical dependence. ü Physical dependence on a medication for treatment of a medical problem does not mean the person is engaging in pathologic use and other behaviors

Common Beliefs about Medication Treatment: Those medications are simply a substitute for heroin or other opioids FACT: The medications are corrective, not curative ü When taken as prescribed, they are safe. ü They allow the person to function normally, not get high. ü They are legally prescribed, not illegally obtained. ü There is a difference between a drug of abuse and a prescribed medication.

Voluntary Drug Use Compulsive Drug Use (Addiction)

Common Beliefs about Medication Treatment: Providing medication alone is sufficient treatment for opioid addiction FACT: Medication is an important treatment option. However, the complete treatment package must include other elements, as well. ücombining pharmacotherapy with counseling and other ancillary services increases the likelihood of success

Common Beliefs about Medication Treatment: Patients are still getting high FACT: When taken as prescribed, the person will feel normal, not high. ü Buprenorphine has a ceiling effect resulting in lowered experience of the euphoria felt at higher doses. ü Naltrexone/Vivitrol has non-narcotic effects ü Methadone is highly medically monitored

Partial Agonist Medication Partial-Agonist Therapy: Buprenorphine A synthetic opioid Described as a mixed opioid agonist-antagonist (or partial agonist) Available for use by certified providers outside traditionally licensed opioid treatment programs Nurse practitioners and physicians assistants have just been allowed to treat under CARA Bill

Partial Agonist Activity Levels 100 90 80 70 Full Agonist (e.g. heroin) EFFECT 60 50 But due to its ceiling maximum opioid agonist effect is never achieved 40 30 Partial Agonist (e.g. buprenorphine) 20 10 0 no drug low dose At therapeutic levels, act similar to full agonists DRUG DOSE high dose

How do we Treat Addiction in the Healthcare Field???

We Wait for the Pyxis Alarm to Sound.. In Healthcare we Strive to: Educate, Prevent, and Intervene In caring for our own: we wait for the Pyxis Alarm The Full Code Human Resources, Legal, Security, Nursing, and BORN

Proactive Response: Workplace Education and Engagement Mandate education in the workplace Orientation, yearly, and booster sessions Integrate addiction education into the environment : Diversion, addiction disease stigma, safety, interventions, and reporting Normalize, allow for communication, empathy, support Open environment Increase self disclosure, staff disclosures Decrease harm, improve outcomes Treats the disease Supports employees, job security Builds alliances

Workplace Reporting Open environment that supports reporting Believe in the system, value to the employee and patient care Doesn t see it as punitive Removes the cover up not wanting to get involved Removes the Stigma: Social, Structural, Personal Engages the employees Maintains transparency EAP can be of great service: typically under-utilized

Thinking Differently Educate all staff Normalize the Disease: Talking, accepting, acknowledging, supporting Integrate addiction treatment, education, prevention, resources in environment Stories, disclosures, personal stories.. Powerful Empower staff to Report, to self disclose, to engage in treatment Monitored practice is a lot safer than impaired practice Hire employees in Recovery, in discipline programs Don t Fire staff who get Help

Treating the Whole Person Psycho-social Interventions Address: Health Psychological Social issues Promotes behavior changes Improves Outcomes Addressing the route of the addiction: life stressors, mental health, physical, personal, and family issues

How to Treat Opioid Use Disorder in the Professional Practice Setting? Length of Treatment Evidence based treatment What treatment are allowed in professional settings Partial and full agonist treatment often not allowed in practice Is it realistic to expect professional with a Chronic, Relapsing, Brain disease to stay abstinent without agonist medications? Is it more harmful to require abstinence Does an abstience model promote more: underground prescribing,treatment, nondisclosure Would the benefit outweigh Risk: long term treatment When do you stop you insulin? When you stop your insulin what happens?

After 5 years if you are sober, you probably will stay that way. Extended Abstinence is Predictive of Sustained Recovery It takes a year of abstinence before less than half relapse 36% Dennis et al, Eval Rev, 2007

How Long is Long ENOUGH. Then WHAT? Five years remains the Gold Standard But then what? Chronic, Relapsing, Disease Disease Remission: Includes Follow up What chronic, relapsing disease do we stop treating Should we think differently here? Routine follow up Random urines several times a year Engagement

Opioid Withdrawal Syndrome Protracted Symptoms Deep muscle aches and pains Insomnia, disturbed sleep Poor appetite Reduced libido, impotence, anorgasmia Depressed mood, anhedonia Drug craving and obsession

The Physician Health Services Model Advocacy Programs Engage and empower their providers Give Back Routine follow up Random urine screening Promotes public Safety and well being Supports the individual and their disease Acknowledges ones accomplishments

Opportunity for Change Leverage the epidemic Acceptance of the disease Ending the Stigma Social Structural Self Removing the shame Integration of treatment into medicine Advances in Treatment Changing our Language

Engage the Nursing Community Education on the problem in nursing Implement education across organizations Disease education: remove stigma Open environment: resources, support Train staff to recognize Empower to support and assist vs. enable, cover Offer a HAND UP..Before Crisis

Opioid Epidemic Front and Center : Seize the moment Solutions, changes, interventions Thinking outside the Box. Workplace?? Forgottten Healthcare: High Impact, High Liability Quality Measures, deliverables: outcomes, evidence based practice Need to invest in the workforce First... Educate, Identify, Support, Treat

Our lives begin to end the day we become silent about things that matter Martin Luther King Jr. How do we meet our goals, objectives, metrics without First Caring for our Employees, Families, and community?